Furthermore, the alteration of the EMT, adipogenesis, and PI3K-Akt-mTOR signaling pathways were found, which indicates that these pathways may participate in mediating the impact of METTL3 on RCC (100, 101). Here, METTL3 is linked to renal cell carcinoma.